| Financial Year |
March 31 2023 |
| Monetary Funds |
4,401,728,376.54 |
| Held-for-trading Financial Assets |
141,557,020.00 |
| Notes Receivable |
262,331,033.30 |
| Accounts Receivable |
2,198,016,524.77 |
| Advances to Suppliers |
69,340,617.23 |
| Other Receivables |
67,955,766.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
10,826,754.49 |
| Dividend Receivable |
-- |
| Inventories |
1,867,793,289.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,580,134.24 |
| Total Current Assets |
9,444,412,963.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,184,979.13 |
| Investment Properties |
-- |
| Fixed Assetes |
1,305,333,436.90 |
| Under-construction Projects |
514,857,093.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
216,806,041.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,106,674.09 |
| Deferred Income Tax Assets |
1,868,280.28 |
| Other Non-Current Assets |
130,899,777.02 |
| Sub-Total of Non-Current Assets |
2,202,951,729.07 |
| Total Assets |
11,647,364,692.27 |
| Short-Term Loans |
1,024,498,006.93 |
| Trading Financial liabilities |
972,800.00 |
| Notes Payable |
2,325,339,653.66 |
| Accounts Payable |
495,064,231.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,326,795.32 |
| Taxes Payable |
20,837,858.33 |
| Interest Payable |
-- |
| Dividend Payable |
5,610.00 |
| Other payables |
105,159,674.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
302,527,162.70 |
| Other Current Liabilities |
4,912,825.35 |
| Sub-Total of Current Liabilities |
4,350,635,977.73 |
| Long-term Loans |
200,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
30,926,004.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
326,620,578.74 |
| Total Liabilities |
4,677,256,556.47 |
| Paid-In Capital(Or Share Stock) |
837,956,198.00 |
| Capital Surplus |
4,477,742,828.65 |
| Surplus Reserve |
201,853,430.19 |
| LESS:Treasury Stock |
16,543,191.60 |
| Undistributed Profits |
1,459,800,097.43 |
| Minority Stockholder's Interest |
3,579,815.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,966,528,319.97 |
| Owner's Equity（Stockholder's Equity） |
6,970,108,135.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,647,364,692.27 |
